Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFH9B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,183
Award facts
- Contract value 100% obligated
- $23,182.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,182.81 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL) on December 12, 2025, with a completion date of December 15, 2025. This competitive, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a primary pharmaceutical distributor for federal medical procurement.
This delivery order supports the Defense Logistics Agency's Medical Supply Chain by procuring Dupixent, a biologic immunosuppressant medication used to treat conditions such as atopic dermatitis, eosinophilic esophagitis, and asthma. AmerisourceBergen's comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare systems globally. The firm's extensive federal contract portfolio and demonstrated capacity to fulfill competitive procurements across multiple therapeutic domains position it as a critical vendor within the federal medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FFH9B?
SPE2DR26FFH9B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FFH9B worth?
The government has obligated $23,183 on SPE2DR26FFH9B.
Is contract SPE2DR26FFH9B an order under another contract?
Yes. SPE2DR26FFH9B is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFH9B competed?
The extent of competition for SPE2DR26FFH9B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award